[SCHEDULE 13G] PRECIGEN, INC. SEC Filing

Rhea-AI Filing Summary

William H. Miller III Living Trust dated April 17, 2017 filed a Schedule 13G reporting beneficial ownership of 34,051,925 shares of Precigen, Inc. common stock, representing 9.2% of the class as presented in the filing. The reported amount includes 16,666,667 shares that the reporting person could acquire within 60 days upon exercise of warrants. The filing states the reporting person has sole voting and sole dispositive power over the reported shares.

The percent calculation in the filing is based on 298,455,084 shares outstanding plus an additional 54,937,411 shares delivered upon conversion of preferred stock and the 16,666,667 warrant shares referenced above. The trust certified the holdings are not intended to influence control of the issuer.

Positive

• Substantial disclosed stake: 34,051,925 shares representing 9.2% of the class as reported
• Sole voting and dispositive power over the reported shares, enabling clear authority over votes
• Transparency on exercisable warrants: filing explicitly states inclusion of 16,666,667 shares exercisable within 60 days

Negative

• None.

Insights

Financial Analyst

TL;DR: A single trust reports a meaningful ~9.2% economic stake including exercisable warrants; this is material ownership that analysts should note.

The filing discloses a significant position of 34,051,925 shares with sole voting and dispositive power, and includes 16,666,667 warrant shares exercisable within 60 days. For valuation and ownership cap-table analysis, the inclusion of exercisable warrants is important because it increases potential dilution and effective stake calculations. The filing cites a pro forma base of 298,455,084 shares plus reported conversions totaling 54,937,411 shares, which materially affects the percentage ownership denominator used.

Corporate Governance Expert

TL;DR: The trustee holds unilateral voting and disposition authority over a sizable block; disclosure is routine but relevant for governance considerations.

The trust reports sole voting and dispositive power over the 34,051,925 shares, which signals concentrated control at the shareholder level without shared governance arrangements. The certification asserts the position is not held to influence control. From a governance perspective, a near-double-digit reported stake warrants monitoring for any future coordination, nominations, or proposals, though the filing itself contains no indication of activist intent.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

PRECIGEN, INC.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

74017N105

(CUSIP Number)

06/26/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 74017N105

1

Names of Reporting Persons

William H. Miller III Living Trust dated April 17, 2017

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

FLORIDA

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 34,051,925.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 34,051,925.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

34,051,925.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.2 %

12

Type of Reporting Person (See Instructions)

OO

Comment for Type of Reporting Person: Note (A) for Lines 5, 7, and 9 - Includes 16,666,667 shares of Common Stock that the Reporting Person could acquire within 60 days upon the exercise of warrants. Note (B) for Line 11 - Based on 298,455,084 shares of Common Stock outstanding as of September 11, 2025, as reported to the Reporting Person by the Issuer's Chief Financial Officer, plus (i) an additional 54,937,411 shares of Common Stock delivered to certain holders of the Issuer's preferred stock upon the conversion of the same, as reported in the Issuer's Current Report on Form 8-K, as filed with the Securities and Exchange Commission on September 17, 2025, and (ii) an additional 16,666,667 shares of Common Stock that the Reporting Person could acquire within 60 days upon the exercise of warrants.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: PRECIGEN, INC.
(b)	Address of issuer's principal executive offices: 85 10th Ave., 9th Floor, New York, NY 10011
Item 2.
(a)	Name of person filing: William H. Miller III Living Trust dated April 17, 2017
(b)	Address or principal business office or, if none, residence: 1104 Kenilworth Drive, Suite 301 Towson, MD 21204
(c)	Citizenship: Florida
(d)	Title of class of securities: Common Stock
(e)	CUSIP No.: 74017N105
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 34,051,925 shares of Common Stock See Row (9) of the cover page of the Reporting Person above and associated Note (A).
(b)	Percent of class: 9.2% See Row (11) of the cover page of the Reporting Person above and associated Note (B).
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 34,051,925 shares See Row (5) of the cover page of the Reporting Person above and associated Note (A).
	(ii) Shared power to vote or to direct the vote: 0 shares
	(iii) Sole power to dispose or to direct the disposition of: 34,051,925 shares See Row (7) of the cover page of the Reporting Person above and associated Note (A).
	(iv) Shared power to dispose or to direct the disposition of: 0 shares
Item 5.	Ownership of 5 Percent or Less of a Class.
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

William H. Miller III Living Trust dated April 17, 2017

Signature:	/s/ William H. Miller III
Name/Title:	William H. Miller III, Trustee
Date:	09/23/2025

FAQ

How many Precigen (PGEN) shares does the William H. Miller III Living Trust report owning?

The filing reports 34,051,925 shares of Precigen common stock beneficially owned by the trust.

What percent of PGEN does the trust's holding represent?

The filing states the reported position represents 9.2% of the outstanding class based on the denominators provided.

Does the filing include any shares exercisable from warrants?

Yes. The reported amount includes 16,666,667 shares that could be acquired within 60 days upon exercise of warrants.

Does the trust have voting control over the reported PGEN shares?

Yes. The trust reports sole voting power and sole dispositive power over the 34,051,925 shares.

Did the trust state an intent to influence control of Precigen (PGEN)?

The certification in Item 10 states the securities were not acquired and are not held to change or influence control of the issuer.